高级检索
当前位置: 首页 > 详情页

IL-34 mediates acute kidney injury and worsens subsequent chronic kidney disease

文献详情

资源类型:

收录情况: ◇ 自然指数

单位: [a]Laboratory of Molecular Autoimmune Disease, Brigham and Women's Hospital, Boston, MA, United States [b]Renal Division, Department of Medicine, Brigham and Women's Hospital, Boston, MA, United States [c]Department of Nephrology and Rheumatology, Johannes-Gutenberg University Mainz, Mainz, Germany [d]Harvard Stem Cell Institute, Cambridge, MA, United States [e]Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO, United States [f]Tongji Hospital, Huazhong University of Science and Technology, Wuhan, China
出处:
ISSN:

摘要:
Macrophages (Mø) are integral in ischemia/reperfusion injury-incited (I/R-incited) acute kidney injury (AKI) that leads to fibrosis and chronic kidney disease (CKD). IL-34 and CSF-1 share a receptor (c-FMS), and both cytokines mediate Mø survival and proliferation but also have distinct features. CSF-1 is central to kidney repair and destruction. We tested the hypothesis that IL-34-dependent, Mø-mediated mechanisms promote persistent ischemia-incited AKI that worsens subsequent CKD. In renal I/R, the time-related magnitude of Mø-mediated AKI and subsequent CKD were markedly reduced in IL-34-deficient mice compared with controls. IL-34, c-FMS, and a second IL-34 receptor, protein-tyrosine phosphatase ζ (PTP-ζ) were upregulated in the kidney after I/R. IL-34 was generated by tubular epithelial cells (TECs) and promoted Mø-mediated TEC destruction during AKI that worsened subsequent CKD via 2 distinct mechanisms: enhanced intrarenal Mø proliferation and elevated BM myeloid cell proliferation, which increases circulating monocytes that are drawn into the kidney by chemokines. CSF-1 expression in TECs did not compensate for IL-34 deficiency. In patients, kidney transplants subject to I/R expressed IL-34, c-FMS, and PTP-ζ in TECs during AKI that increased with advancing injury. Moreover, IL-34 expression increased, along with more enduring ischemia in donor kidneys. In conclusion, IL-34-dependent, Mø-mediated, CSF-1 nonredundant mechanisms promote persistent ischemia-incited AKI that worsens subsequent CKD. © 2015, American Society for Clinical Investigation. All rights reserved.

语种:
中科院(CAS)分区:
出版当年[2014]版:
大类 | 1 区 医学
小类 | 1 区 医学:研究与实验
最新[2025]版:
大类 | 1 区 医学
小类 | 1 区 医学:研究与实验
第一作者:
第一作者单位: [a]Laboratory of Molecular Autoimmune Disease, Brigham and Women's Hospital, Boston, MA, United States [b]Renal Division, Department of Medicine, Brigham and Women's Hospital, Boston, MA, United States
通讯作者:
通讯机构: [a]Laboratory of Molecular Autoimmune Disease, Brigham and Women's Hospital, Boston, MA, United States [b]Renal Division, Department of Medicine, Brigham and Women's Hospital, Boston, MA, United States
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:434 今日访问量:0 总访问量:419 更新日期:2025-05-01 建议使用谷歌、火狐浏览器 常见问题

版权所有:重庆聚合科技有限公司 渝ICP备12007440号-3 地址:重庆市两江新区泰山大道西段8号坤恩国际商务中心16层(401121)